Ligand validation:6MZE

GTP: GUANOSINE-5'-TRIPHOSPHATE

GTP is a Ligand Of Interest in 6MZE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MZE_GTP_J_600	41%	32%	0.203	0.919	1.12	1.58	2	7	0	0	100%	1
6MZE_GTP_Q_600	40%	31%	0.228	0.939	1.13	1.6	2	7	0	0	100%	1
6MZE_GTP_H_600	35%	21%	0.245	0.935	1.18	2.08	2	7	0	0	100%	1
6MZE_GTP_V_600	35%	32%	0.254	0.943	1.12	1.57	2	7	0	0	100%	1
6MZE_GTP_A_600	34%	31%	0.241	0.926	1.13	1.6	2	7	0	0	100%	1
6MZE_GTP_C_600	34%	31%	0.236	0.92	1.12	1.59	2	7	0	0	100%	1
6MZE_GTP_O_600	31%	32%	0.238	0.906	1.12	1.58	2	7	0	0	100%	1
6MZE_GTP_X_600	30%	32%	0.239	0.906	1.13	1.57	2	7	0	0	100%	1
8QEA_GTP_A_501	100%	60%	0.039	0.982	0.95	0.59	1	-	0	0	100%	1
8QL6_GTP_A_501	99%	57%	0.041	0.98	0.97	0.69	1	-	0	0	100%	1
7YYQ_GTP_A_501	99%	46%	0.06	0.994	1.04	1.05	1	2	0	0	100%	1
8WMU_GTP_C_501	99%	36%	0.052	0.982	1.2	1.33	1	5	0	0	100%	1
9F8G_GTP_A_501	99%	36%	0.052	0.979	1.18	1.32	1	6	0	0	100%	1
5VQ2_GTP_A_201	100%	38%	0.023	0.997	1.17	1.26	2	6	0	0	100%	1
1PLK_GTP_A_167	100%	37%	0.036	0.997	1.16	1.29	3	3	3	0	100%	1
1O3Y_GTP_B_1001	100%	43%	0.046	0.991	1	1.19	1	3	0	0	100%	1
1QRA_GTP_A_167	100%	1%	0.044	0.988	4.3	3.51	11	12	0	0	100%	1
4GNQ_GTP_A_701	100%	50%	0.045	0.989	0.91	1	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.